浏览全部资源
扫码关注微信
1.南阳市中心医院,河南 南阳 473000
2.荆州市第二人民医院消化内科,湖北 荆州 434000
3.南阳市中心医院呼吸内科,河南 南阳 473000
4.广西中医药大学附属瑞康医院消化内科,南宁 530011
硕士。研究方向:消化系统肿瘤的研究和诊治。 E-mail:ysx005512@163.com
教授,博士。研究方向:消化系统疾病的研究和诊治。E-mail:cyn60668@aliyun.com
纸质出版日期:2023-10-15,
收稿日期:2023-04-01,
修回日期:2023-08-15,
扫 描 看 全 文
尹硕鑫,敖先伟,李博等.清热化湿方通过上调miRNA-155抑制Wnt/β-catenin信号通路治疗胃癌的作用机制研究 Δ[J].中国药房,2023,34(19):2339-2343.
YIN Shuoxin,AO Xianwei,LI Bo,et al.Mechanism study of Qingre huashi decoction in the treatment of gastric cancer by up-regulating miRNA-155 and inhibiting Wnt/β-catenin signaling pathway[J].ZHONGGUO YAOFANG,2023,34(19):2339-2343.
尹硕鑫,敖先伟,李博等.清热化湿方通过上调miRNA-155抑制Wnt/β-catenin信号通路治疗胃癌的作用机制研究 Δ[J].中国药房,2023,34(19):2339-2343. DOI: 10.6039/j.issn.1001-0408.2023.19.07.
YIN Shuoxin,AO Xianwei,LI Bo,et al.Mechanism study of Qingre huashi decoction in the treatment of gastric cancer by up-regulating miRNA-155 and inhibiting Wnt/β-catenin signaling pathway[J].ZHONGGUO YAOFANG,2023,34(19):2339-2343. DOI: 10.6039/j.issn.1001-0408.2023.19.07.
目的
2
研究清热化湿方干预miRNA-155抑制Wnt/
β
-catenin信号通路治疗胃癌的作用机制。
方法
2
将30只裸鼠随机分为模型组、对照组(0.004 g/kg顺铂+0.02 g/kg氟尿嘧啶)、过表达组和清热化湿方低、中、高剂量组(2.71、5.43、10.86 g/kg),每组5只。过表达组接种过表达miRNA-155 AGS细胞,其余各组均接种AGS细胞,以复制胃癌荷瘤模型。对照组腹腔注射相应药物,其余各组灌胃相应药物或生理盐水,每天1次,连续3周。测定各组裸鼠的肿瘤组织质量,观察肿瘤组织的病理学形态,检测肿瘤组织中miRNA-155以及Wnt7、
β
-catenin、T细胞因子4(TCF-4)蛋白和mRNA表达水平。
结果
2
与模型组比较,对照组、过表达组及清热化湿方高剂量组裸鼠肿瘤组织质量均显著降低(
P
<0.05);Wnt7、
β
-catenin、TCF-4 mRNA和蛋白表达水平均显著降低(
P
<0.05),miRNA-155表达水平均显著升高(
P
<0.05);肿瘤细胞均出现不同程度的排列疏松,核染色较浅,出现坏死灶。
结论
2
清热化湿方可通过上调miRNA-155,抑制Wnt/
β
-catenin信号通路中Wnt7、
β
-catenin、TCF-4 mRNA和蛋白的表达,进而抑制胃癌荷瘤模型裸鼠的瘤体生长。
OBJECTIVE
2
To study the mechanism of Qingre huashi decoction in the treatment of gastric cancer by intervening in miRNA-155 and inhibiting Wnt/
β
-catenin signaling pathway.
METHODS
2
Thirty nude mice were randomly divided into model group, control group (0.004 g/kg cisplatin+0.02 g/kg fluorouracil), overexpression group, Qingre huashi prescription low-dose, medium-dose and high-dose groups (2.71, 5.43, 10.86 g/kg), with 5 mice in each group. The overexpression group was inoculated with miRNA-155 AGS cell line, and the other groups were inoculated with AGS cells to induce tumor-bearing gastric cancer model. The control group was given relevant medicine intraperitoneally, and other groups were given relevant medicine or normal saline intragastrically, once a day, for 3 consecutive weeks. The weight of tumor tissue in nude mice was determined; the pathological morphology of tumor tissue was observed; the miRNA-155 expression, mRNA and protein expressions of Wnt7,
β
-catenin and T-cell factor-4(TCF-4) in tumor tissue were detected.
RESULTS
2
Compared with the model group, the tumor weights of nude mice in the control group, the overexpression group and Qingre huashi decoction high-dose group were significantly reduced (
P
<0.05); mRNA and protein expressions of Wnt7,
β
-catenin and TCF-4 were significantly decreased (
P
<0.05), while miRNA-155 expression was increased significantly (
P
<0.05). Tumor cells exhibited varying degrees of loose arrangement, shallow nuclear staining, and necrotic foci.
CONCLUSIONS
2
Qingre huashi decoction can inhibit the protein and mRNA expressions of Wnt7,
β
-catenin and TCF-4 in Wnt/
β
-catenin signaling pathway by up-regulating miRNA-155, thus inhibiting the tumor growth of tumor-bearing nude mice.
清热化湿方miRNA-155胃癌Wnt7β-cateninT细胞因子4
miRNA-155gastric cancerWnt7β-cateninT-cell factor-4
SMYTH E C,NILSSON M,GRABSCH H I,et al. Ga- stric cancer[J]. Lancet,2020,396(10251):635-648.
WANG F H,ZHANG X T,LI Y F,et al. The Chinese Society of Clinical Oncology (CSCO):clinical guidelines for the diagnosis and treatment of gastric cancer,2021[J]. Cancer Commun,2021,41(8):747-795.
SEENEEVASSEN L,BESSÈDE E,MÉGRAUD F,et al. Gastric cancer:advances in carcinogenesis research and new therapeutic strategies[J]. Int J Mol Sci,2021,22(7):3418.
黄李冰雪,张涛,钟婵,等. 基于网络药理学的清热化湿方治疗胃癌的药理机制研究[J]. 中药材,2019,42(10):2375-2384.
HUANG L B X,ZHANG T,ZHONG C,et al. Pharmacological mechanism of Qingre huashi decoction in treatment of gastric cancer based on network pharmacology[J]. J Chin Med Mater,2019,42(10):2375-2384.
黄李冰雪,张涛,钟婵,等. 清热化湿方对MNU联合幽门螺杆菌感染相关胃癌细胞中CD14、NF-κB及IL-6表达的影响[J]. 时珍国医国药,2019,30(5):1053-1057.
HUANG L B X,ZHANG T,ZHONG C,et al. The effect of Qingre huashi decoction on the expression of CD14,NF-κB and IL-6 in gastric cancer cells associated with MNU combined with Helicobacter pylori infection[J].Lishizhen Med Mater Res,2019,30(5):1053-1057.
钟婵,张涛,黄李冰雪,等. 清热化湿方对MNU联合幽门螺杆菌感染小鼠胃组织中TNF-α、IL-8及TLR-4水平的影响[J]. 中成药,2020,42(5):1339-1343.
ZHONG C,ZHANG T,HUANG L B X,et al. The effect of Qingre huashi decoction on the levels of TNF-α,IL-8 and TLR-4 in gastric tissue of mice infected with MNU combined with Helicobacter pylori[J]. Chin Tradit Pat Med,2020,42(5):1339-1343.
ZHANG T,LIU C,HUANG S,et al. A downmodulated microRNA profiling in patients with gastric cancer[J]. Gastroenterol Res Pract,2017,2017:1526981.
赵俊佳,陈远能,张涛,等. miR-155介导TGF-β/SMAD-2信号参与胃癌及清热化湿方的干预研究[J]. 时珍国医国药,2021,32(11):2613-2618.
ZHAO J J,CHEN Y N,ZHANG T,et al. Study on the involvement of TGF-β/SMAD-2 signal mediated by miR-155 in gastric cancer and the intervention of Qingre huashi formula[J]. Lishizhen Med Mater Med Res,2021,32(11):2613-2618.
黄晓婉,孙健,张珏,等. miR-186-5p靶向CXCL13基因通过Wnt/β-catenin信号调节胃癌HGC-27细胞增殖、凋亡、细胞周期、迁移和侵袭[J]. 肿瘤药学,2023,13(3):290-296.
HUANG X W,SUN J,ZHANG Y,et al. miR-186-5p targets CXCL13 gene and regulates the proliferation,apoptosis, cell cycle,migration and invasion of gastric cancer HGC-27 cell through Wnt/β-catenin signaling[J]. Anti Tumor Pharm,2023,13(3):290-296.
陈奇. 中药药理研究方法学[M]. 3版.北京:人民卫生出版社,2011:121.
CHEN Q. Pharmacological research methodology of traditional Chinese medicine[M]. 3rd edition. Beijing:People’s Health Publishing House,2011:121.
张保静,陈远能,张涛. 基于CD14,IL-1β表达及SGC-7901细胞凋亡变化探讨清热化湿方防治胃癌的机制[J]. 中国实验方剂学杂志,2013,19(20):246-250.
ZHANG B J,CHEN Y N,ZHANG T. Effect of Qingre Huashi dectction on regulating SGC-7901 cell apoptosis by mediating CD-14 and IL-1β for prevention and treatment of colon cancer[J].Chin J Exp Tradit Med Formulae,2013,19(20):246-250.
LU T X,ROTHENBERG M E. microRNA[J]. J Allergy Clin Immunol,2018,141(4):1202-1207.
BERSIMBAEV R,PULLIERO A,BULGAKOVA O,et al. Radon biomonitoring and microRNA in lung cancer[J]. Int J Mol Sci,2020,21(6):2154.
LI H L,XIE S P,LIU M,et al. The clinical significance of downregulation of miR-124-3p,miR-146a-5p,miR-155-5p and miR-335-5p in gastric cancer tumorigenesis[J]. Int J Oncol,2014,45(1):197-208.
NUSSE R,CLEVERS H. Wnt/β-catenin signaling,disease,and emerging therapeutic modalities[J]. Cell,2017,169(6):985-999.
YU Z Y,JIANG X Y,QIN L,et al. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination[J]. Oncogene,2021,40(5):1027-1042.
刘博,赵建国,夏爱辉,等. Wnt7a蛋白在胃癌组织中的表达及其与预后的关系[J]. 中国普通外科杂志,2019,28(4):449-455.
LIU B,ZHAO J G,XIA A H,et al. Expression of Wnt7a in gastric cancer tissue and its association with prognosis[J].Chin J Gen Surg,2019,28(4):449-455.
ZENG J H,MA X,ZHAO Z Y,et al. Ginsenoside Rb1 lessens gastric precancerous lesions by interfering with β-catenin/TCF4 interaction[J]. Front Pharmacol,2021,12:682713.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构